TOKYO, Mar 16, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that anti-microtubule binding region (MTBR) tau antibody E2814, which was created from collaboration research between Eisai and University College London, has been selected by the Dominantly InheriteContinue Reading

TOKYO, Mar 12, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally available multiple receptor kinase inhibitor discovered by Eisai, with a prospective indicatioContinue Reading

TOKYO, Mar 10, 2021 – (JCN Newswire via SEAPRWire.com) – As announced by the Alliance, MITSUBISHI MOTORS CORPORATION (MMC) has decided to procure two OEM-model vehicles for Europe from an Alliance member, Groupe Renault. MMC will introduce them to selected markets in Europe through its sContinue Reading

TOKYO, Mar 5, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that the latest data from its Alzheimer’s disease (AD) and dementia pipeline, including the investigational anti-amyloid beta (Aß) protofibril antibody lecanemab (Development Code: BAN2Continue Reading

TOKYO, Mar 4, 2021 – (JCN Newswire via SEAPRWire.com) – Honda Motor Co., Ltd. will begin lease sales in Japan, on March 5, 2021, of the all-new Legend equipped with Honda SENSING Elite. Legend Hybrid EX – Honda SENSING Elite Striving to realize a collision-free society based on itsContinue Reading